SAKAR HEALTHCARE Financial Statement Analysis
|
||
|
The Revenues of SAKAR HEALTHCARE have increased by 4.00% YoY .
The Earnings Per Share (EPS) of SAKAR HEALTHCARE has decreased by -19.85 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
SAKAR HEALTHCARE Last 5 Annual Financial Results
[NSE : SAKAR]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹133 Cr | ₹128 Cr | ₹95 Cr | ₹8,298,024 Cr | ₹83 Cr |
| Expenses | ₹100 Cr | ₹99 Cr | ₹72 Cr | ₹6,343,119 Cr | ₹63 Cr |
| Operating Profit (Excl OI) | ₹33 Cr | ₹29 Cr | ₹23 Cr | ₹1,954,905 Cr | ₹20 Cr |
| Other Income | ₹4.68 Cr | ₹2.17 Cr | ₹1.18 Cr | ₹201,684 Cr | ₹2.02 Cr |
| Interest | ₹5.96 Cr | ₹2.91 Cr | ₹2.50 Cr | ₹225,918 Cr | ₹2.26 Cr |
| Depreciation | ₹15 Cr | ₹9.67 Cr | ₹8.06 Cr | ₹707,981 Cr | ₹7.08 Cr |
| Profit Before Tax | ₹17 Cr | ₹19 Cr | ₹13 Cr | ₹1,222,691 Cr | ₹12 Cr |
| Profit After Tax | ₹13 Cr | ₹15 Cr | ₹11 Cr | ₹962,285 Cr | ₹9.62 Cr |
| Consolidated Net Profit | ₹13 Cr | ₹15 Cr | ₹11 Cr | ₹962,285 Cr | ₹9.62 Cr |
| Earnings Per Share (Rs) | ₹5.37 | ₹6.70 | ₹8.87 | ₹6.84 | ₹6.43 |
| PAT Margin (%) | 7.61 | 9.57 | 11.84 | 11.28 | 11.60 |
| ROE(%) | 5.42 | 8.48 | 13.44 | 11.88 | 11.83 |
| ROCE(%) | 7.42 | 8.95 | 12.09 | 13.16 | 14.79 |
| Total Debt/Equity(x) | 0.31 | 0.69 | 0.73 | 0.43 | 0.20 |
Key Financials |
||
| Market Cap | : | ₹ 628.9 Cr |
| Revenue (TTM) | : | ₹ 164.2 Cr |
| Net Profit(TTM) | : | ₹ 12.4 Cr |
| EPS (TTM) | : | ₹ 5.7 |
| P/E (TTM) | : | 50.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SAKAR HEALTHCARE | -5.6% | -1.5% | -17.5% |
| SUN PHARMACEUTICAL INDUSTRIES | 1% | 4.6% | 47.5% |
| CIPLA | -1.1% | -0.3% | 20.7% |
| DR REDDYS LABORATORIES | 2.2% | 12.1% | 21.6% |
| ZYDUS LIFESCIENCES | -2.7% | 0.8% | 43.8% |
| DIVIS LABORATORIES | 1% | -3.2% | 59.3% |
| MANKIND PHARMA | 0.8% | 12.8% | 52.4% |
| TORRENT PHARMACEUTICALS | -1.5% | 5.9% | 55% |
| LUPIN | 0.9% | 7.2% | 72.7% |
SAKAR HEALTHCARE Revenues
[NSE : SAKAR]
| Y-o-Y | 4.00 % |
| 5 Yr CAGR | 12.59 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹133 Cr | 4.00 | |
| Mar2023 | ₹128 Cr | 35.35 | |
| Mar2022 | ₹95 Cr | -100.00 | |
| Mar2021 | ₹8,298,024 Cr | 9,999,928.87 | |
| Mar2020 | ₹83 Cr | - | |
SAKAR HEALTHCARE Operating Profit
[NSE : SAKAR]
| Y-o-Y | 13.39 % |
| 5 Yr CAGR | 14.21 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹33 Cr | 13.39 | |
| Mar2023 | ₹29 Cr | 29.75 | |
| Mar2022 | ₹23 Cr | -100.00 | |
| Mar2021 | ₹1,954,905 Cr | 9,999,924.55 | |
| Mar2020 | ₹20 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 9.00 % |
| 5 Yr CAGR | 1.43 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 24.94% | 9.00 | |
| Mar2023 | 22.88% | -4.15 | |
| Mar2022 | 23.87% | 1.32 | |
| Mar2021 | 23.56% | 0.00 | |
| Mar2020 | 23.56% | - | |
SAKAR HEALTHCARE Profit After Tax
[NSE : SAKAR]
| Y-o-Y | -15.95 % |
| 5 Yr CAGR | 7.31 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹13 Cr | -15.95 | |
| Mar2023 | ₹15 Cr | 42.09 | |
| Mar2022 | ₹11 Cr | -100.00 | |
| Mar2021 | ₹962,285 Cr | 9,999,739.14 | |
| Mar2020 | ₹9.62 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -20.48 % |
| 5 Yr CAGR | -10.00 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 7.61 % | -20.48 | |
| Mar2023 | 9.57 % | -19.17 | |
| Mar2022 | 11.84 % | 4.96 | |
| Mar2021 | 11.28 % | -2.76 | |
| Mar2020 | 11.6 % | - | |
SAKAR HEALTHCARE Earnings Per Share (EPS)
[NSE : SAKAR]
| Y-o-Y | -19.85 % |
| 5 Yr CAGR | -4.40 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹5.37 | -19.85 | |
| Mar2023 | ₹6.70 | -24.46 | |
| Mar2022 | ₹8.87 | 29.68 | |
| Mar2021 | ₹6.84 | 6.38 | |
| Mar2020 | ₹6.43 | - | |
SAKAR HEALTHCARE Return on Capital Employed (ROCE)
[NSE : SAKAR]
| Y-o-Y | -17.09 % |
| 5 Yr CAGR | -15.84 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 7.42% | -17.09 | |
| Mar2023 | 8.95% | -25.97 | |
| Mar2022 | 12.09% | -8.13 | |
| Mar2021 | 13.16% | -11.02 | |
| Mar2020 | 14.79% | - | |
SAKAR HEALTHCARE Share Price vs Sensex
| Current Share Price | : | ₹289.8 |
| Current MarketCap | : | ₹ 628.9 Cr |
| Updated EOD on | : | Dec 26,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | -5.6% |
-1.5% |
-17.5% |
| SENSEX | -2.1% |
-2% |
11.3% |
SAKAR HEALTHCARE related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about SAKAR HEALTHCARE Financials
How the annual revenues of SAKAR HEALTHCARE have changed ?
The Revenues of SAKAR HEALTHCARE have increased by 4.00% YoY .
How the Earnings per Share (EPS) of SAKAR HEALTHCARE have changed?
The Earnings Per Share (EPS) of SAKAR HEALTHCARE has decreased by -19.85 % YoY .
Check out Intrinsic Value of Peers of SAKAR HEALTHCARE
Compare Stock Analytics of Peers of SAKAR HEALTHCARE
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
